The experiment with protein synthesis inhibitor cycloheximide (CHX), which was used to evaluate the stability of the CD133 protein, showed that oxytetracycline might destabilize CD133 in the liver cancer stem cells. This evidence concerns the gene PROM1 and liver cancer.